drugset / Trial / NCT00998634
Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine safety and tolerability of the treatment with lithium in Spinocerebellar Ataxia 2. Moreover, clinical symptoms, neuronal loss, quality of life and depressive symptoms, will be considered to further investigate the effect of lithium therapy.
Timeline
- Start
- 2009-10
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium Carbonate | Unknown | 150 mg | — |
| Subject | Lithium Carbonate | Unknown | 300 mg | — |